Loring Wolcott & Coolidge Fiduciary Advisors’s Avanos Medical AVNS Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.22K	Buy	+250	New	+$5.85K	﹤0.01%	534
2022 Q1	–	Sell	-72	Closed	-$2K	–	641
2021 Q4	$2K	Hold	72	–	–	﹤0.01%	690
2021 Q3	$2K	Sell	72 -72	-50%	-$2.44K	﹤0.01%	699
2021 Q2	$5K	Buy	+144	New	+$5.96K	﹤0.01%	731
2019 Q3	–	Sell	-31	Closed	-$1K	–	680
2019 Q2	$1K	Hold	31	–	–	﹤0.01%	682
2019 Q1	$1K	Buy	+31	New	+$1.39K	﹤0.01%	666
2018 Q4	–	Sell	-189	Closed	-$13K	–	694
2018 Q3	$13K	Hold	189	–	–	﹤0.01%	520
2018 Q2	$11K	Hold	189	–	–	﹤0.01%	540
2018 Q1	$9K	Hold	189	–	–	﹤0.01%	588
2017 Q4	$9K	Hold	189	–	–	﹤0.01%	574
2017 Q3	$9K	Hold	189	–	–	﹤0.01%	564
2017 Q2	$8K	Hold	189	–	–	﹤0.01%	559
2017 Q1	$7K	Sell	189 -137	-42%	-$5.34K	﹤0.01%	568
2016 Q4	$12K	Buy	326 +137	+72%	+$4.9K	﹤0.01%	513
2016 Q3	$7K	Hold	189	–	–	﹤0.01%	562
2016 Q2	$6K	Hold	189	–	–	﹤0.01%	577
2016 Q1	$5K	Sell	189 -9	-5%	-$240	﹤0.01%	572
2015 Q4	$7K	Hold	198	–	–	﹤0.01%	579
2015 Q3	$8K	Hold	198	–	–	﹤0.01%	556
2015 Q2	$8K	Hold	198	–	–	﹤0.01%	556
2015 Q1	$10K	Sell	198 -18	-8%	-$834	﹤0.01%	559
2014 Q4	$10K	Buy	+216	New	+$8.49K	﹤0.01%	553

Other funds holding AVNS

SRC

Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

CIEC

Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return

TMAM

Tokio Marine Asset Management Tokyo, Japan $3.23B AUM 37.2% 1-Year Est. Return

KIM

Kestrel Investment Management San Mateo, California $184M AUM 31.66% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's AVNS Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors opened a new position in Avanos Medical (AVNS) in Q2 2026: 250 shares worth $6.22K. The stake represents ﹤0.01% of the portfolio and ranks #534 among its holdings. This is a return to the name: Loring Wolcott & Coolidge Fiduciary Advisors previously reported a position in AVNS as recently as Q4 2021.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in AVNS in Q4 2014 and has held it in 22 quarters since. The position peaked at $13K in Q3 2018. 109 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Loring Wolcott & Coolidge Fiduciary Advisors held 250 shares of Avanos Medical worth $6.22K as of Q2 2026.
Avanos Medical was a new Loring Wolcott & Coolidge Fiduciary Advisors position in Q2 2026.
Avanos Medical made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #534 holding.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Avanos Medical in Q4 2014 and has held it in 22 quarters since.
Loring Wolcott & Coolidge Fiduciary Advisors's Avanos Medical position peaked at $13K in Q3 2018.
109 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.